Regulation of the sodium pump during cardiomyocyte adaptation to pregnancy

Experimental Physiology

Volumn 98, Issue 1, 2013, Pages 183-192

  Elzwiei, F ^a,b   Bassien Capsa, V ^a,b   St Louis, J ^a,b   Chorvatova, A ^a,c  

^a UNIVERSITY OF MONTREAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c INTERNATIONAL LASER CENTER   (Slovakia)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); OUABAIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE;

ADAPTATION; ANIMAL CELL; ARTICLE; BIRTH; CELL FUNCTION; CELL METABOLISM; CELL SIZE; CONCENTRATION RESPONSE; CONFOCAL MICROSCOPY; ENZYME ANALYSIS; ENZYME REGULATION; FEMALE; HEART MUSCLE CELL; HOMEOSTASIS; MITOCHONDRION; NONHUMAN; OXIDATION REDUCTION STATE; PATCH CLAMP; PREGNANCY; PROTEIN EXPRESSION; RAT; SODIUM CELL LEVEL; WESTERN BLOTTING;

EID: 84872187915     PISSN: 09580670     EISSN: 1469445X     Source Type: Journal    
DOI: 10.1113/expphysiol.2012.066282     Document Type: Article

References (45)

1. Amler E, Cester N, Magnanelli R, Mazzanti L, Kotyk A & Romanini C (1994a). Na, K-ATPase from placenta of women with pregnancy-induced hypertension exhibits an increased affinity for cardiac glycosides. Physiol Res 43, 33-36.
2. Amler E, Cester N, Salvolini E, Staffolani R, Burkhard M, Mazzanti L, Kotyk A & Romanini C (1994b). Human hypertensive placenta contains an increased amount of Na, K-ATPase with higher affinity for cardiac glycosides. Cell Biol Int 18, 723-727.
3. Bassien-Capsa V, Elzwiei FM, Aneba S, Fouron JC, Comte B & Chorvatova A (2011). Metabolic remodelling of cardiac myocytes during pregnancy: the role of mineralocorticoids. Can J Cardiol 27, 834-842.
4. Bassien-Capsa V, Fouron JC, Comte B & Chorvatova A (2006). Structural, functional and metabolic remodeling of rat left ventricular myocytes in normal and in sodium-supplemented pregnancy. Cardiovasc Res 69, 423-431.
5. Battista MC, Calvo E, Chorvatova A, Comte B, Corbeil J & Brochu M (2005). Intra-uterine growth restriction and the programming of left ventricular remodelling in female rats. J Physiol 565, 197-205.
6. Beausejour A, Auger K, St-Louis J & Brochu M (2003). High-sodium intake prevents pregnancy-induced decrease of blood pressure in the rat. Am J Physiol Heart Circ Physiol 285, H375-H383.
7. Bilbaut A, Chorvatova A, Ojeda C & Rougier O (1996). The transient outward current of isolated bovine adrenal zona fasciculata cells: comparison between standard and perforated patch recording methods. J Membr Biol 149, 233-247.
8. Bird DK, Yan L, Vrotsos KM, Eliceiri KW, Vaughan EM, Keely PJ, White JG & Ramanujam N (2005). Metabolic mapping of MCF10A human breast cells via multiphoton fluorescence lifetime imaging of the coenzyme NADH. Cancer Res 65, 8766-8773.
9. 2+ stores and cell responsiveness. Am J Physiol 264, C1367-C1387.
10. Chance B (1976). Pyridine nucleotide as an indicator of the oxygen requirements for energy-linked functions of mitochondria. Circ Res 38, I31-I38.
11. Chorvat D Jr & Chorvatova A (2006). Spectrally resolved time-correlated single photon counting: a novel approach for characterization of endogenous fluorescence in isolated cardiac myocytes. Eur Biophys J 36, 73-83.
12. Chorvat D Jr & Chorvatova A (2009). Multi-wavelength fluorescence lifetime spectroscopy: a new approach to the study of endogenous fluorescence in living cells and tissues. Laser Physics Letters 6, 175-193.
13. Chorvat D Jr, Mateasik A, Cheng Y, Poirier N, Miro J, Dahdah NS & Chorvatova A (2010). Rejection of transplanted hearts in patients evaluated by the component analysis of multi-wavelength NAD(P)H fluorescence lifetime spectroscopy. J Biophotonics 3, 646-652.
14. Chorvatova A, Elzwiei F, Mateasik A & Chorvat D Jr (2012). Effect of ouabain on metabolic oxidative state in living cardiomyocytes evaluated by time-resolved spectroscopy of endogenous NAD(P)H fluorescence. Journal of Biomedical Optics 17, 101505-1-7.
15. 2+ release in catecholamine-induced cardiac hypertrophy. Cardiovasc Res 61, 278-287.
16. Eisner DA & Smith GL (1992). The Na-K pump and its effectors in cardiac muscle. In The Heart and Cardiovascular System, ed. Fozzard HA, Haber R, Jennings RB, Katz AM & Morgan HE, pp. 863-902. Raven Press, New York.
17. Fedorova OV, Kolodkin NI, Agalakova NI, Namikas AR, Bzhelyansky A, St-Louis J, Lakatta EG & Bagrov AY (2005). Antibody to marinobufagenin lowers blood pressure in pregnant rats on a high NaCl intake. J Hypertens 23, 835-842.
18. Fuller W, Parmar V, Eaton P, Bell JR & Shattock MJ (2003). Cardiac ischemia causes inhibition of the Na/K ATPase by a labile cytosolic compound whose production is linked to oxidant stress. Cardiovasc Res 57, 1044-1051.
19. Gabbe SG, Niebyl JR & Simpson JL (2002). Obstetrics Normal and Problem Pregnancies, Churchill Livingstone, A Harcourt Health Science Company, Philadelphia.
20. Gao J, Mathias RT, Cohen IS & Baldo GJ (1995). Two functionally different Na/K pumps in cardiac ventricular myocytes. J Gen Physiol 106, 995-1030.
21. Golden KL, Ren J, O'Connor J, Dean A, DiCarlo SE & Marsh JD (2001). In vivo regulation of Na/Ca exchanger expression by adrenergic effectors. Am J Physiol Heart Circ Physiol 280, H1376-H1382.
22. Graves SW, Lincoln K, Cook SL & Seely EW (1995). Digitalis-like factor and digoxin-like immunoreactive factor in diabetic women with preeclampsia, transient hypertension of pregnancy, and normotensive pregnancy. Am J Hypertens 8, 5-11.
23. Heenan AP, Wolfe LA, Davies GA & McGrath MJ (2003). Effects of human pregnancy on fluid regulation responses to short-term exercise. J Appl Physiol 95, 2321-2327.
24. Jacobs BE, Liu Y, Pulina MV, Golovina VA & Hamlyn JM (2012). Normal pregnancy: mechanisms underlying the paradox of a ouabain-resistant state with elevated endogenous ouabain, suppressed arterial sodium calcium exchange, and low blood pressure. Am J Physiol Heart Circ Physiol 302, H1317-H1329.
25. Jensen E, Wood C & Keller-Wood M (2002). The normal increase in adrenal secretion during pregnancy contributes to maternal volume expansion and fetal homeostasis. J Soc Gynecol Investig 9, 362-371.
26. Linke A, Li W, Huang H, Wang Z & Hintze TH (2002). Role of cardiac eNOS expression during pregnancy in the coupling of myocardial oxygen consumption to cardiac work. Am J Physiol Heart Circ Physiol 283, H1208-H1214.
27. Liu T, Brown DA & O'Rourke B (2010). Role of mitochondrial dysfunction in cardiac glycoside toxicity. J Mol Cell Cardiol 49, 728-736.
28. Lopatin DA, Ailamazian EK, Dmitrieva RI, Shpen VM, Fedorova OV, Doris PA & Bagrov AY (1999). Circulating bufodienolide and cardenolide sodium pump inhibitors in preeclampsia. J Hypertens 17, 1179-1187.
29. Martinka E, Ochodnický M & Mokán M (1996). Digoxin-like immunoactivity in pregnant women with diabetes mellitus. Am J Hypertens 9, 516.
30. Mészáros J, Khananshvili D & Hart G (2001). Mechanisms underlying delayed afterdepolarizations in hypertrophied left ventricular myocytes of rats. Am J Physiol Heart Circ Physiol 281, H903-H914.
31. + pump. Circ Res 86, 37-42.
32. Mootha VK, Arai AE & Balaban RS (1997). Maximum oxidative phosphorylation capacity of the mammalian heart. Am J Physiol 272, H769-H775.
33. 2+ concentrations. J Biol Chem 260, 4028-4034.
34. Niesner R, Peker B, Schlüsche P & Gericke KH (2004). Noniterative biexponential fluorescence lifetime imaging in the investigation of cellular metabolism by means of NAD(P)H autofluorescence. Chemphyschem 5, 1141-1149.
35. Nishio M, Ruch SW, Kelly JE, Aistrup GL, Sheehan K & Wasserstrom JA (2004). Ouabain increases sarcoplasmic reticulum calcium release in cardiac myocytes. J Pharmacol Exp Ther 308, 1181-1190.
36. Rae J, Cooper K, Gates P & Watsky M (1991). Low access resistance perforated patch recordings using amphotericin B. J Neurosci Methods 37, 15-26.
37. Romashko DN, Marban E & O'Rourke B (1998). Subcellular metabolic transients and mitochondrial redox waves in heart cells. Proc Natl Acad Sci USA 95, 1618-1623.
38. +-ATPase. Biochim Biophys Acta 988, 185-220.
39. +-ATPase isoforms in myocardium. Isoform change in deoxycorticosterone acetate-salt hypertension. Circ Res 74, 669-678.
40. Swynghedauw B (1999). Molecular mechanisms of myocardial remodeling. Physiol Rev 79, 215-262.
41. + concentration and altered Na/K pump activity in hypertrophied canine ventricular cells. Cardiovasc Res 57, 1035-1043.
42. White RL & Wittenberg BA (2000). Mitochondrial NAD(P)H, ADP, oxidative phosphorylation, and contraction in isolated heart cells. Am J Physiol Heart Circ Physiol 279, H1849-H1857.
43. +-ATPase as a signal transducer. Eur J Biochem 269, 2434-2439.
44. +-ATPase-mediated signal transduction: from protein interaction to cellular function. Mol Interv 3, 157-168.
45. +-ATPase to hypertrophy and its marker genes in cardiac myocytes. J Biol Chem 274, 19323-19328.